Factors Informing Individualized Treatment Decision-Making for HER2-Positive Metastatic Breast Cancer

Treatment with Enhertu “is an unprecedented approval” for patients with HER2-positive solid tumors who did not have many options, an expert told CURE®.

One cancer vaccine may still be years away from being available, a breast cancer test may be misguiding treatments for Black women and the review of two oncology regimens are being expedited by the FDA.

Finding support as a cancer survivor helps me get through the unpredictable twists and turns of cancer.

CURE® recently covered the San Antonio Breast Cancer Symposium. In case you missed it, here is some news that came out of the conference that patients should know about.

Researchers have found that treatment with antibody-drug conjugates is associated with fatigue among patients with breast cancer.

My metastatic breast cancer has caused metastases to my brain, so it's important I advocate for my brain when symptoms arise.